| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |